Advantages and quality control of orally disintegrating tablets

Fabad Journal of Pharmaceutical Sciences

Volumn 34, Issue 3, 2009, Pages 167-172

  Ölmez, Senem Sevtap ^a   Vural, Imran ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Advantages; Orally disintegrating tablets; Quality control

Indexed keywords

EID: 84859796744     PISSN: 13004182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Peck GE, Baley GJ, McCurdy VE, Banker GS. Tablet formulation and design. In: Lieberman H, Lachman L, Scwartz JB, editor. Pharmaceutical Dosage Forms: Tablets. New York: Marcel Dekker Inc; 1989. p. 75-130.
2. Seager H. Drug-delivery products and the Zydis fast-dissolving dosage form. J Pharm Pharmacol 50: 375-382, 1998. (Pubitemid 28197414)
3. European Pharmacopeia 6th ed. Strasburg, France; 2007.
4. Guidance for Industry Orally Disintegrating Tablets, FDA CDER Data Standards Manual; 2008.
5. Habib W, Khankari R, Hontz J. Fast dissolve drug delivery systems. Crit Rev Ther Drug Carrier Syst 17: 61-72, 2000. (Pubitemid 30174149)
6. Brown D. Orally disintegrating tablets- taste over speed. Drug Deliv Technol 3: 58-61, 2003.
7. Shukla D, Chakraborty S, Singh S, Mishra B. Mouth dissolving tablets I: An overview of formulation technology. Sci Pharm 76: 309-326, 2009.
8. Dobetti L. Fast melting tablets: Developments and technologies. Pharm Technol Drug Deliv 44- 50, 2001.
9. Sastry SV, Nyshadham JR, Fix JA. Recent technological advances in oral drug delivery - A review. Pharm Sci Technolo Today 3: 138-145, 2000. (Pubitemid 30195827)
10. Bandari S, Mittapalli RK, Gannu R, Rao YM. Orodispersible tablets: An overview. Asian Journal of Pharmaceutics 2-11, 2008.
11. Koch WM. Swallowing disorders, diagnosis and therapy. Med Clin North Am 77: 571-582, 1993.
12. Frijlink HW. Benefits of different drug formulations in psychopharmacology. Eur Neuropsychopharmacol 13 Suppl 3: S77-84, 2003. (Pubitemid 37188778)
13. Behnke K, Sogaard J, Martin S, Bauml J, Ravindran AV, Agren H, Vester-Blokland ED. Mirtazapine orally disintegrating tablet versus sertraline: A prospective onset of action study. J Clin Psychopharmacol 23: 358-364, 2003. (Pubitemid 36951177)
14. Chang R, Guo X, Burnside BA, Couch R. Fast- dissolving tablets. Pharm Tech 24: 52-58, 2000.
15. Virely P, Yarwood R. Zydis - A novel, fast dissolving dosage form. Manuf Chem 61: 36-37, 1990.
16. Lew MF. Selegiline orally disintegrating tablets for the treatment of Parkinson's disease. Expert Rev Neurother 5: 705-12, 2005. (Pubitemid 41679638)
17. Fu Y, Yang S, Jeong SH, Kimura S, Park K. Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies. Crit Rev Ther Drug Carrier Syst 21: 433-76, 2004.
18. Bharawaj S, Jain V, Sharma S, Jat RC, Jain S. Orally disintegrating tablets: A review. Drug Invention Today 2: 81-88, 2010.
19. Goel H, Rai P, Rana V, Tiwary AK. Orally disintegrating systems: Innovations in formulation and technology. Recent Patents on Drug Delivery & Formulation 2: 258-274, 2008.
20. Prajapati BG, Ratnakar N. A review on recent patents on fast dissolving drug delivery system. Int J PharmTech Res 1: 790-798, 2009.
21. Anand V, Kandarapu R, Garg S. Preparation and evaluation of taste-masked orally disintegrating tablets of prednisolone. Asian J Pharm Sci 2: 227- 238, 2007.
22. Abdelbary G, Prinderre P, Eouani C, Joachim J, Reynier JP, Piccerelle P. The preparation of orally disintegrating tablets using a hydrophilic waxy binder. Int J Pharm 278: 423-33, 2004. (Pubitemid 38759514)
23. Kuno Y, Kojima M, Ando S, Nakagami H. Effect of preparation method on properties of orally disintegrating tablets made by phase transition. Int J Pharm 355: 87-92, 2008.
24. Swamy PV, Shahidulla SM, Shirsand SB, Hiremath SN, Ali Y. Orodispersible tablets of carbamazepine prepared by direct compression method using 32 full factorial design. Dhaka Univ J Pharm Sci 7: 1-5, 2008.
25. Jadon RS et al. Taste masking of Lornoxicam by polymer carrier system and formulation of oral disintegrating tablets. Int J Drug Del 1: 27-31, 2009.
26. Gupta A, Mishra AK, Gupta V, Bansal P, Singh R, Singh AK. Recent Trends of Fast Dissolving Tablet - An Overview of Formulation Technology. IJPBA 1: 1-10, 2010.
27. Sznitowska M, Placzek M, Klunder M. The psysical characteristics of lyophilized tablets containing a model drug in different chemical forms and concentrations. Acta Poloniae Pharmaceutica - Drug Research 62: 25-29, 2005. (Pubitemid 350056436)
28. Corveleyn S, Remon JP. Formulation and production of rapidly disintegrating tablets by lyophilisation using hydrochloorothiazide as a model drug. Int J Pharm 152: 215-225, 1997. (Pubitemid 27290596)
29. Bi Y, Sunada H, Yonezawa Y, Danjo K, Otsuka A, Iida K. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull (Tokyo) 44: 2121-7, 1996. (Pubitemid 26396765)
30. Sunada H, Bi Y. Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder Technol 122:188-198, 2002. (Pubitemid 34041549)
31. Schiermeier S, Schmidt PC. Fast dispersible ibuprofen tablets. Eur J Pharm Sci 15: 295-305, 2002. (Pubitemid 34229144)
32. Bi YX, Sunada H, Yonezawa Y, Danjo K. Evaluation of rapidly disintegrating tablets prepared by a direct compression method. Drug Dev Ind Pharm 25: 571-581, 1999. (Pubitemid 29186288)
33. Sugimoto M, Narisawa S, Matsubara K, Yoshino H, Nakano M, Handa T. Development of manufacturing method for rapidly disintegrating oral tablets using the crystalline transition of amorphous sucrose. Int J Pharm 320: 71-8, 2006. (Pubitemid 44128706)
34. Bi Y, Yonezawa Y, Sunada H. Rapidly disintegrating tablets prepared by the wet compression method: Mechanism and optimization. J Pharm Sci 88: 1004-1010, 1999. (Pubitemid 29480591)
35. Wagh MA, Dilip KP, Salunkhe KS, Chavan NV, Daga VR. Techniques used in orally disintegrating drug delivery system. Int J Drug Deliv 2: 98-107, 2010.
36. Bharawaj S, Jain V, Sharma S, Jat RC, Jain S. Orally disintegrating tablets: A review. DIT 2: 81- 88, 2010.
37. Rao NGR, Ketan T, Suresh DK. Formulation and evaluation of mouth dissolving tablets of metoprolol tartrate by sublimation method. Int J Pharm Bio Sci 1: 1-14, 2010.
38. Siewert M, Dressman J, Brown CK, Shah VP. FIP/ AAPS guidelines to dissolution / in vitro release testing of novel / special dosage forms. AAPS Pharm Sci Tech 4: Article 7, 2003.
39. Klancke J. Dissolution Testing of Orally Disintegrating Tablets. Dissolution Technol 10: 6-8, 2003.
40. Rawas-Qalaji MM, Simons FE, Simons KJ. Fast- disintegrating sublingual tablets: Effect of epinephrine load on tablet characteristics. AAPS PharmSciTech 7: E41, 2006.
41. Fu Y, Yang S, Jeong SH, Kimura S, Park K. Orally fast disintegrating tablets: Developments, technologies, taste-masking and clinical studies. Crit Rev Ther Drug Carrier Syst 21: 433-76, 2004.
42. Abdelbary G, Eouani C, Prinderre P, Joachim J, Reynier J, Piccerelle P. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int J Pharm 292: 29-41, 2005. (Pubitemid 40255786)
43. Que L, Wu W, Cheng X, Hu T. Evaluation of disintegrating time of rapidly disintegrating tablets by a paddle method. Pharm Dev Technol 11: 295-301, 2006. (Pubitemid 44221683)
44. Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S. A new formulation for orally disintegrating tablets using a suspension spray- coating method. Int J Pharm 382: 80-87, 2009.
45. Shu T, Suzuki H, Hironaka K, Ito K. Studies of rapidly disintegrating tablets in the oral cavity using co-ground mixtures of mannitol with crospovidone. Chem Pharm Bull (Tokyo) 50: 193-8, 2002. (Pubitemid 41694579)
46. Sugimoto M, Narisawa S, Matsubara K, Yoshino H, Nakano M, Handa T. Effect of formulated ingredients on rapidly disintegrating oral tablets prepared by the crystalline transition method. Chem Pharm Bull (Tokyo) 54: 175-80, 2006. (Pubitemid 43200593)
47. Fukami J, Yonemochi E, Yoshihashi Y, Terada K. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose. Int J Pharm 310: 101-9, 2006. (Pubitemid 43287972)
48. Que L, Wu W, Cheng X, Hu T. Evaluation of disintegrating time of rapidly disintegrating tablets by a paddle method. Pharm Dev Technol 295-301, 2006. (Pubitemid 44221683)
49. El-Arini SK, Clas SD. Evaluation of disintegration testing of different fast dissolving tablets using the texture analyzer. Pharm Dev Technol 7: 361-71, 2002. (Pubitemid 34983127)
50. Morita Y, Tsushima Y, Yasui M, Termoz R, Ajioka J, Takayama K. Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera. Chem Pharm Bull (Tokyo) 50: 1181-6, 2002. (Pubitemid 41656829)
51. Narazaki R, Harada T, Takami N, Kato Y, Ohwaki T. A new method for disintegration studies of rapid disintegrating tablet. Chem Pharm Bull 52: 704-707, 2004. (Pubitemid 41685508)
52. Harada T, Narazaki R, Nagira S, Ohwaki T, Aoki S, Iwamoto K. Evaluation of the disintegration properties of commercial famotidine 20 mg orally disintegarting tablets using a simple new test and human sensory test. Chem Pharm Bull 54: 1072-1075, 2006. (Pubitemid 44166393)